SHP503-803: Drug Utilization Study with Intuniv® in Australia

Study identification

• EU PAS number:
  EUPAS40684
• Study ID:
  44620
• Official title and acronym:
  SHP503-803: Drug Utilization Study with Intuniv® in Australia
• DARWIN EU® study:
  No
• Study countries:
  Australia
• Study description:
  This study will evaluate and analyze prescribing behaviors of physicians and determine whether Intuniv was correctly prescribed in Australia.
• Study status:
  Finalised

Research institutions and networks

Institutions

Shire

Study timelines

Date when funding contract was signed

Actual: 30/05/2017

Study start date

Actual: 11/03/2019

Data analysis start date

Actual: 01/05/2019

Date of interim report, if expected

Actual: 28/08/2020

Date of final study report

Actual: 27/08/2021

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Shire

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  Non-EU RMP only

Other study registration identification numbers and links

CT.gov: NCT04866030,To obtain more information on the study, click here/on this link: https://clinicaltrials.takeda.com/study-detail/609017abf89629001e47b500